Comparison of Triflusal and Clopidogrel in Secondary Prevention of Stroke Based on the Genotyping

NCT01174693 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

795

Enrollment

OTHER

Sponsor class

Conditions

Cerebral Infarction

Interventions

DRUG: Triflusal
DRUG: Clopidogrel

Sponsor

Gangnam Severance Hospital

Collaborators

[object Object]
[object Object]